Lupin
Saravanan Dorai is an experienced professional in quality control within the biopharmaceutical industry. Currently serving as Head of Quality Control at Lupin since August 2022, Saravanan is responsible for batch releases, stability testing, method transfers, validations, and compliance. Prior to this role, Saravanan was the Senior Director of Quality Control at Biocon Biologics from July 2021 to August 2022, overseeing critical QC operations, including audits and training. Saravanan's earlier experience at Biocon from June 2003 to June 2021 as Senior Manager QC involved leading technology and method transfers to renowned international organizations while ensuring validation processes aligned with customer and market requirements. Saravanan holds a degree in Chemistry from Cordite Factory, completed between 1987 and 1994.
This person is not in any teams
This person is not in any offices
Lupin
16 followers
Lupin is a global pharmaceutical company offering Branded and Generic Formulations, Biosimilars and Active Pharmaceutical Ingredients (APIs). Founded over 50 years ago, Lupin today is a significant player in the US, India and Japan and additionally in other counties within APAC, EMEA and LATAM. It holds a global leadership position in Anti-TB and Cephalosporin segments.